VIDAL
Medicines
Parallel Import Medicine
This medicine has been the subject of a parallel import authorisation.
The information for this specialty (except for the Reimbursement section) is that of the specialty PERMIXON 160 mg, capsules which obtained a marketing authorisation (AMM) in France.
Please note that the excipients may be different from those of the specialty that obtained the marketing authorisation (AMM) in France.
Refer to the monograph of the specialty PERMIXON 160 mg, capsules.
SANT JOSEP 116 NAVE 2 SANT FELIU DE LLOBREGAT, B
08980 BARCELONA
Tel: 44 (0)3306 841 100 Tel (green number): 09 72 10 61 79
regulatory.france@difarmed.com
http://www.difarmed.com/
Medicines
Parallel Import Medicine
PERMIXON 160 mg, capsules [ES1]
This medicine has been the subject of a parallel import authorisation.
The information for this specialty (except for the Reimbursement section) is that of the specialty PERMIXON 160 mg, capsules which obtained a marketing authorisation (AMM) in France.
Please note that the excipients may be different from those of the specialty that obtained the marketing authorisation (AMM) in France.
Refer to the monograph of the specialty PERMIXON 160 mg, capsules.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
| Price: |
|
Social Security reimbursement at 30% (B/60, B/180).
Collect (B/180).
Difarmed SL
Collect (B/180).
SANT JOSEP 116 NAVE 2 SANT FELIU DE LLOBREGAT, B
08980 BARCELONA
Tel: 44 (0)3306 841 100 Tel (green number): 09 72 10 61 79
regulatory.france@difarmed.com
http://www.difarmed.com/
Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.
